Sharps Compliance — Investor Presentation (May 2009)
22 slides from Sharps Compliance's investor presentation, May 14, 2009
Slide 1: Sharps: Defining Change Through Innovation
SHARPS Defining Change Through Innovation
Slide 2: Safe Harbor Statement
Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “estimate”, “anticipate”, “project” and “expect” and similar expressions are in
Slide 3: Sharps Compliance Corp.
Sharps Compliance Corp. Sharps Compliance Corp. is a fully integrated provider of cost-effective disposal solutions for medical and pharmaceutical waste generated outside the hospital setting utilizing the USPS or UPS. Our strategy is to capitalize on our leadership position and continue to penetrat
Slide 4: Sharps Compliance Corp.
Sharps Compliance Corp. NASDAQ: SMED • Market capitalization* $68.1 million • 52-week range* $5.34 - - $2.10 • Recent price* $5.28 • Total shares outstanding 12.9 million • Avg. daily trading volume (3 mos.) 12,414 • Ownership: • Institutional (estimated) 25% • Insider 60% • Fiscal Year-End June 30
Slide 5: Target Markets
Target Markets • Federal, State and Municipal Governments • Pharmaceutical Manufacturers • Hospitality • Retail Clinic • Commercial / Industrial • Professional • Agriculture • Home Infusion Distribution network, strong telesales approach & targeted Internet marketing Direct Sales: Regional and targe
Slide 6: Vertically Integrated Solutions Provider
Vertically Integrated Solutions Provider Treatment Facility Distribution Facility Data to Client Internet-based tracking system SharpsTracer™ DrugTracer™ Products in use Customer
Slide 7: Vendor-Managed Inventory Solutions
Vendor-Managed Inventory Solutions $40 million contract with an agency of the U.S. Government 6 Patient Support Programs in place with major pharmaceutical manufacturers Sharps Proprietary Medical Waste Management System (Sharps®MWMS™) ü Integrates flagship Sharps Disposal By Mail System (“SDBM”) wi
Slide 8: Products and Services
Products and Services RxTakeAway™ Medical Professional Sharps Disposal by Mail System® Sharps Secure® Sharps Disposal by Mail System®
Slide 9: RxTakeAway: Convenient medication disposal solution
RxTakeAway™ Convenient and confidential medication disposal solution Safe, eco-friendly way to protect your family, community and environment Market opportunities: Individual consumers, retail pharmacies, alternate care facilities and community programs Source: U.S. Health & Human Services 2008 Enve
Slide 10: Government Regulation
Government Regulation Sharps Disposal Legislation for Self-Injectors Source: Coalition for Safe Community Needle Disposal MAP KEY States with legislation banning trash disposal of self-injector’s sharps States interested in introducing legislation States with guidance, but do not regulate self-injec
Slide 11: Financial Highlights
Financial Highlights
Slide 12: Sharps financial strengths
SHARPS. Operating Leverage Strong Margins t Mover Advantage Early Market Penetration Recurring Revenue
Slide 13: Rapid Revenue Growth
Rapid Revenue Growth Fiscal Year Revenue (in millions) Year CAGR = 13.8% (Q3 - TTM) Revenue more than doubles in FY 2009 3 rd quarter $8.6 $9.0 $10.6 $12.0 $12.8 $16.4
Slide 14: Stable Gross Margins
Stable Gross Margins Fiscal Year Gross Margin Gross margin was 59.2% in Q3 FY 2009 Company expects gross margins to exceed 50% going forward (Q3 - TTM) 40.7% 38.9% 42.5% 41.9% 39.8% 46.4%
Slide 15: Operating Leverage
Operating Leverage Fiscal Year Operating Margin * Excludes $138,000 Q3 FY 2007 special charge (Q3 - TTM) Operating margin was 33.2% in Q3 FY 2009 Beginning to recognize the operating leverage inherent in business -0.8% -1.9% 3.6% 7.2% 0.0% 11.5% 2007*
Slide 16: Bottom-line Profitability
Bottom-line Profitability ($0.01) ($0.02) $0.02 $0.075 $0.01 $0.09 Fiscal Year Net Income (in thousands) Earnings Per Share *Excludes $138 thousand Q3 FY 2007 special charge **Excludes $1.8 million, or $0.13 per diluted share, income tax benefit recorded in Q2 FY (Q3 - TTM) -$118 $382 $920 $81 $1,25
Slide 17: Strong Balance Sheet
Strong Balance Sheet Working Capital $3.6M Shareholder Equity Growth Q3 07 vs. Q3 09 333% Line of Credit Term sheet with Bank to increase to $4.5 million $2.5M (As of and for the period ending March 31, 2009) No debt as of 3/31/09
Slide 18: Strategy and Outlook
Strategy and Outlook
Slide 19: Converging Factors for Success
Converging Factors for Success Vertical integration Own treatment, facility 37 tons per day ‘capacity ‘2 Conynige Snape Compliance Corporation 2008 SHARPS. 18
Slide 20: Investment Potential
Investment Potential Leader in all markets outside of hospital Recognized name brand Value-added products and services Consistent high-quality performance Powerful operating leverage Developing strong, nationwide customer base Vertically Integrated
Slide 21: Sharps: Defining Change Through Innovation
SHARPS Defining Change Through Innovation
Slide 22: Sharps product descriptions
+ SDBM + Sharps©MWMS™ + RxTakeAway™ + Sharps Secure SHARPS. - Sharps Disposal By Mail Systeme ‘Acosteffectve and easjto-use system forte proper csposal of used needles, syrnges, and otner ‘smal quantites of bio hazardous waste. The disposal soliton is weal for maiviouals who seltnect or macicalfacit